Zetta Genomics has expanded its second seed round, attracting new investment and growth expertise. With £6.2 million secured over two years, Zetta scales global operations and customer offerings to transform precision medicine and personalised healthcare. Fast-scaling genomic data pioneer, Zetta Genomics, has expanded its second seed round – securing an additional £1.8 million and strengthening investor expertise. […]
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain Boston, MA, Rolle, Switzerland and Madrid, Spain – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination […]
Direct integration allows customers to stream data from Element’s AVITI™ System directly to DNAnexus SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision Health Data Cloud, to allow customers to stream data from Element’s AVITI™ System directly to their DNAnexus account. The collaboration combines the […]
BOZEMAN, Mont — Golden Helix, Inc. announced that it has received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. It is specifically tailored to the medical device industry […]
New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer panel at 3377x coverage in just 6 minutes for less than $0.72 per test Included in market-leading CLC Genomics analysis platform for desktop, server or cloud use Enhances QDI’s leading portfolio of NGS analysis and […]
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian […]
Trusted research environment provides secure access to high-quality, de-identified whole genome sequencing data and associated medical records MOUNTAIN VIEW, Calif. & BOSTON — DNAnexus, Inc., the provider of the Precision Health Data Cloud, and TMA Precision Health, a global health platform for rare diseases, today announced a collaboration to advance basic and translational research for patients […]
Analysis platform enables powerful, accessible single cell data exploration SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage. With the acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface. By […]
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care in India Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Karkinos Healthcare, a purpose-driven […]
Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK. As a leading pharmaceutical company engaged in research and development across multiple locations worldwide and a previous customer of Qlucore, the license enables global utilization of Qlucore Omics Explorer software. Qlucore Omics Explorer is […]
Pay Invoice
Latest Blogs
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
-
Spatial Biology and Spatial Omics Imaging Systems
November 29, 2023 6:34 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.